Rule 144 Filing: Insider Sales by Dhananjay Prasanna Include Multiple Transactions

Rhea-AI Filing Summary

Form 144 notice indicates a proposed sale of 900 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $64,998.00. The filing shows the shares were acquired as restricted stock on 08/20/2024 and the proposed approximate sale date is 10/01/2025. The issuer's total shares outstanding are listed as 609,584,000.

The document also records multiple sales by the same person, Dhananjay Prasanna, totaling sizable quantities across July–September 2025, including transactions of 5,659 shares on 08/21/2025 and several other sales (e.g., 3,600 shares on 08/15/2025 and 08/01/2025). The filer attests they are not aware of undisclosed material adverse information and the notice includes standard Rule 144 representations.

Positive

• Provides full Rule 144 disclosure for the proposed sale including broker, amount, aggregate market value, and approximate sale date
• Includes detailed record of prior dispositions by the same person with dates and gross proceeds, aiding transparency
• Filer attests there is no undisclosed material adverse information, consistent with regulatory requirements

Negative

• Significant insider selling activity is shown in July–September 2025 (e.g., 5,659 shares on 08/21/2025), which may be viewed negatively by some investors
• Filing lacks issuer name and some contact fields are incomplete in the provided extract, limiting immediate context about the issuer

Insights

Securities Analyst

TL;DR: Routine insider sale notice showing ongoing dispositions by an insider; not clearly material to company operations.

The filing documents a proposed sale of 900 restricted shares and lists numerous recent sales by the same individual totaling several thousand shares across July–September 2025. With 609,584,000 shares outstanding, the proposed sale of 900 shares represents a de minimis fraction of outstanding stock. The disclosure is consistent with Rule 144 compliance and provides transparent market-impact data by citing aggregate market value for the proposed sale as $64,998.00.

Corporate Compliance Officer

TL;DR: Filing meets Rule 144 reporting requirements and includes attestation; shows active selling, which warrants monitoring for pattern but is procedurally compliant.

The Form 144 lists acquisition as restricted stock on 08/20/2024 and notes the filer’s attestation about absence of undisclosed material adverse information. Multiple prior sales by the filer are detailed with dates and gross proceeds, supporting aggregation requirements under Rule 144. From a compliance perspective, the document contains the necessary broker, amounts, and timing to satisfy notice obligations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	900	64998.00	609584000	10/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2024	Restricted Stock	Issuer			900	08/20/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	09/30/2025	200	15064.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	09/15/2025	900	66051.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	09/02/2025	900	68616.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/25/2025	400	32000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/21/2025	5659	417181.48
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/15/2025	3600	274284.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/08/2025	400	32796.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	08/01/2025	3600	269748.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/23/2025	800	64000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/17/2025	800	56000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/15/2025	2800	190568.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/02/2025	800	56000.00
DHANANJAY PRASANNA 1955 Broadway, Suite 600 Oakland CA 94612	Common	07/01/2025	2800	189672.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed under symbol BSQKZ report?

The Form 144 reports a proposed sale of 900 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $64,998.00, approximate sale date 10/01/2025.

Who is the seller named in the filing?

The seller listed for recent transactions is Dhananjay Prasanna at the provided address, with multiple sales recorded between July and September 2025.

When were the securities acquired that are proposed to be sold?

The 900 shares proposed for sale were acquired as restricted stock on 08/20/2024 and payment is noted as not applicable.

How many shares does the issuer have outstanding according to the filing?

The filing lists 609,584,000 shares outstanding.

Does the filing indicate any undisclosed material information?

The filer signs an attestation representing they do not know of any material adverse information about the issuer that has not been publicly disclosed.